Predicting the individualized risk of poor adherence to ART medication among adolescents living with HIV in Uganda: the Suubi+Adherence study
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the International AIDS Society"
DOI: 10.1002/jia2.25756
Abstract: Achieving optimal adherence to antiretroviral therapy (ART) among adolescents living with HIV (ALWHIV) is challenging, especially in low‐resource settings. To help accurately determine who is at risk of poor adherence, we developed and internally validated… read more here.
Keywords: risk poor; adolescents living; among adolescents; poor adherence ... See more keywords
141Are Older Patients At High Risk Of Adverse Health Outcomes Identified In Hospital
Sign Up to like & getrecommendations! Published in 2017 at "Age and Ageing"
DOI: 10.1093/ageing/afx068.141
Abstract: Introduction: Older people represent nearly two-third of admissions to hospitals in the UK, and many are at high risk of poor healthcare outcomes including long length of stay and admission to care homes. Early identification… read more here.
Keywords: risk poor; risk; staff; high risk ... See more keywords
Association between Working Hours and Self-Rated Health
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph17082736
Abstract: This study compared the association between working hours and self-rated health (SRH) according to sex, socioeconomic status, and working conditions. In all, 25,144 participants were selected from the Korea National Health and Nutrition Examination Survey… read more here.
Keywords: risk poor; working hours; short hours; poor srh ... See more keywords
In persons at risk for poor vaccination response or COVID-19 exposure, tixagevimab + cilgavimab reduced COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Internal Medicine"
DOI: 10.7326/j22-0056
Abstract: SOURCE CITATION Levin MJ, Ustianowski A, De Wit S, et al. Intramuscular AZD7442 (tixagevimab-cilgavimab) for prevention of Covid-19. N Engl J Med. 2022;386:2188-200. 35443106. read more here.
Keywords: covid; tixagevimab cilgavimab; risk poor; persons risk ... See more keywords